White Bronco, you and Bizzy and Pete raise good points. Kind of makes my head spin. The need for anti-virals remains, and that train will keep on track, let's hope B is among the proven leaders. My hunch, as I am typing, is that newly revised monoclonal anti-bodies will also be joining the frey.